ArticleAlzheimer's research & therapy2021

Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease.

Luke Whiley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.